Clinical Trial Update: Ramipril in Rheumatoid Arthritis [Phase 2, Phase 3]

View source ↗

Summary

A completed clinical trial evaluating ramipril for rheumatoid arthritis, spanning Phase 2 and Phase 3, conducted by the University of Zurich.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Ramipril (ramipril)

Snippet

Sponsor: University of Zurich | Conditions: Arthritis, Rheumatoid | Phase 2, Phase 3 | Status: COMPLETED